Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical chitosan-coated spironolactone nanoparticles for acne vulgaris
IRCT20120707010203N11Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of spironolactone and clindamycin in acne vulgaris (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Non-inflammatory lesions and Inflammatory lesions. Started Oct 2020; status: completed.
02
Drugs
spironolactoneclindamycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20120707010203N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120707010203N11.